StonvexLoading…
StonvexStonvexStonvexCore line items from IDYA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Annual 2024 2024-12-31 |
|---|---|---|---|---|
Revenue | $6.56M | $218.71M | $207.83M | $7.00M |
Operating Income | $-108.54M | $-159.31M | $-64.74M | $-326.98M |
Net Income | $-98.54M | $-113.70M | $-30.43M | $-274.48M |
EPS (Diluted) | $-1.11 | $-1.28 | $-0.34 | $-3.36 |
Total Assets | $1.03B | $1.11B | $1.19B | $1.12B |
Total Liabilities | $93.08M | $86.39M | $93.10M | $64.94M |
Cash & Equivalents | $157.52M | $112.83M | $298.93M | $84.38M |
Free Cash Flow OCF − CapEx | $-76.14M | $-73.47M | $17.36M | $-251.44M |
Shares Outstanding | 87.86M | 87.80M | 87.67M | 86.50M |